[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1952

CLINICAL USE OF FAT INJECTED INTRAVENOUSLY

Author Affiliations

BOSTON

From the Department of Nutrition, Harvard School of Public Health, the Medical and Surgical Clinics, Peter Bent Brigham Hospital, and the Surgical Service, Massachusetts General Hospital.

AMA Arch Intern Med. 1952;89(3):353-357. doi:10.1001/archinte.1952.00240030002001
Abstract

A MAJOR problem in parenteral feeding is associated with the need for a nonsclerosing preparation for intravenous administration which contains a large supply of calories in a small volume of fluid. Fat emulsions appear to offer a solution to this problem. Fat particles do not exert an osmotic effect; accordingly, fat may be injected in high concentrations without damage to veins and in a relatively small fluid volume. Unlike dextrose and amino acids, fat is not excreted in the urine in significant amounts.

Among the earliest clinical studies involving the intravenous administration of fat emulsions for caloric purposes was one reported by Yamakawa in Japan in 1920.1 Later, in this country, Holt, Tidwell, and Scott2 studied the effect of intravenous fat administration in experimental animals and in children.

In the interim, although fat emulsions for intravenous administration still have not become available commercially, their use in man is

First Page Preview View Large
First page PDF preview
First page PDF preview
×